Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Carcinoma Resectable”

268 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 268 results

Early research (Phase 1)Study completedNCT02578602
What this trial is testing

MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer

Who this might be right for
Adult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaBCLC Stage 0 Adult Hepatocellular Carcinoma+6 more
University of Southern California 26
Not applicableWithdrawnNCT00892255
What this trial is testing

Microwave Ablation of Resectable Liver Tumors

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
St. Joseph Hospital of Orange
Testing effectiveness (Phase 2)Looking for participantsNCT06405061
What this trial is testing

Evaluation of Effectiveness and Safety of HAIC in Combination With Adebrelimab and Bevacizumab for Potentially Resectable Hepatocellular Carcinoma

Who this might be right for
AdebrelimabHepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 40
Not applicableLooking for participantsNCT07305428
What this trial is testing

Downstaging Unresectable Hepatocellular Carcinoma to Resectable Disease With Combined Immunotherapy and Stereotactic Beamed Radiotherapy: a Pilot Study

Who this might be right for
HCC - Hepatocellular CarcinomaUnresectable Hepatocellular Carcinoma
The University of Hong Kong 30
Testing effectiveness (Phase 2)UnknownNCT04718909
What this trial is testing

Regorafenib Plus Sintilimab vs. Regorafenib as the Second-line Treatment for HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 166
Testing effectiveness (Phase 2)Looking for participantsNCT05265208
What this trial is testing

Selective Internal Radiation Therapy and Capecitabine (Chemotherapy) Treatment for Liver Cancer

Who this might be right for
Resectable Intrahepatic Cholangiocarcinoma
Center Eugene Marquis 62
Testing effectiveness (Phase 2)UnknownNCT02452853
What this trial is testing

HR Combined With FOLFOX4 for HCC With PVTT

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 51
Testing effectiveness (Phase 2)Looking for participantsNCT04522544
What this trial is testing

Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectableHCC
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 55
Not applicableNot Yet RecruitingNCT04996914
What this trial is testing

Adjuvant Stereotactic Body Radiation Therapy After Trans-arterial Chemoembolization in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
RWTH Aachen University 30
Testing effectiveness (Phase 2)Looking for participantsNCT05844046
What this trial is testing

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients

Who this might be right for
Hepatocellular Carcinoma
Enrico De Toni 83
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Not applicableUnknownNCT04967495
What this trial is testing

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 171
Early research (Phase 1)UnknownNCT04592029
What this trial is testing

TACE Combined With Sintilimab and Bevacizumab for Unresectable HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 36
Not applicableUnknownNCT05621499
What this trial is testing

HAIC or Lenvatinib Combined With Sintilimab for High Recurrence Risk Resectable Solitary Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Tianjin Medical University Cancer Institute and Hospital 60
Large-scale testing (Phase 3)Looking for participantsNCT05608200
What this trial is testing

Lenvatinib+Sintilimab+TACE vs. Lenvatinib+TACE for Advanced HCC

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Second Affiliated Hospital of Guangzhou Medical University 427
Testing effectiveness (Phase 2)WithdrawnNCT06994299
What this trial is testing

A Pilot Trial of Preoperative Irradiation With the STRIDE (Single Dose of Tremelimumab With Ongoing Durvalumab) Regimen (PRISM) for Resectable/Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma (HCC)
Weill Medical College of Cornell University
Not applicableLooking for participantsNCT05953337
What this trial is testing

Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular CarcinomaHepatocellular Carcinoma Non-resectableLiver Cancer
ABK Biomedical 120
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07131501
What this trial is testing

A Single-Arm, Multicenter, Exploratory Clinical Study of TACE Combined With Iparomlimab and Tuvonralimab Injection (QL1706) and Lenvatinib for Perioperative Treatment of Resectable Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmunotherapyPreoperative+2 more
The First Affiliated Hospital with Nanjing Medical University 48
Not applicableLooking for participantsNCT06487663
What this trial is testing

TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant Tumors

Who this might be right for
Hepatocellular Carcinoma Non-resectableCholangiocarcinoma Non-resectableLiver Metastases+1 more
Tianjin Medical University Cancer Institute and Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00712790
What this trial is testing

Study of SIR-Spheres Plus Sorafenib as 1st Line Treatment for Non-resectable Primary Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Singapore Clinical Research Institute 35
Load More Results